A61K39/0018 - CPC Classification Index

#1

20250049906

2025-02-13

IMMUNOGENIC COMPOSITIONS

#2

20240226262

2024-07-11

Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins

#3

20240131137

2024-04-25

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

#4

20230357300

2023-11-09

TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS

#5

20230201325

2023-06-29

Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a tetanus toxoid and a diphtheria toxoid

#6

20230165950

2023-06-01

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

#7

20210346483

2021-11-11

Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same

#8

20210299237

2021-09-30

TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS

#9

20210121546

2021-04-29

Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers

#10

20200206331

2020-07-02

Immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof

#11

20200138927

2020-05-07

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

#12

20200000911

2020-01-02

IMMUNOGENIC COMPOSITION

#13

20190298822

2019-10-03

Immunogenic composition

#14

20190125851

2019-05-02

Therapeutic compositions and methods with cytokine signaling immunomodulators

#15

20190076518

2019-03-14

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

#16

20180256695

2018-09-13

COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT

#17

20180243395

2018-08-30

Injectable vaccines against multiple meningococcal serogroups

#18

20180177871

2018-06-28

Adjuvanted formulations of booster vaccines

#19

20180169204

2018-06-21

Combination vaccines with lower doses of antigen and/or adjuvant

#20

20180104324

2018-04-19

Immunogenic composition

#21

20180064806

2018-03-08

Immunogenic composition

#22

20170065714

2017-03-09

Immunogenic composition

#23

20160354457

2016-12-08

Injectable vaccines against multiple meningococcal serogroups

#24

20160263216

2016-09-15

Adjuvanted formulations of booster vaccines

#25

20160038582

2016-02-11

Vaccines for the prevention of infections with

#26

20160015804

2016-01-21

Vaccine combinations

#27

20150273036

2015-10-01

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

#28

20150224204

2015-08-13

Immunogenic composition

#29

20150224185

2015-08-13

Immunogenic compositions

#30

20150125486

2015-05-07

ADJUVANTED FORMULATIONS OF PEDIATRIC ANTIGENS

#31

20150044253

2015-02-12

Immunogenic composition

#32

20150037368

2015-02-05

Polyanionic polymer adjuvants for Haemophilus influenzae B saccharide vaccines

#33

20140339126

2014-11-20

Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

#34

20140220073

2014-08-07

Immunization compositions and methods

#35

20140112950

2014-04-24

COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT

#36

20130273101

2013-10-17

Vaccine for inducing an improved immune reaction

#37

20130266609

2013-10-10

VACCINE COMPOSITION

#38

20130236492

2013-09-12

Adjuvanted formulations of booster vaccines

#39

20130004536

2013-01-03

Multiple vaccination including serogroup C meningococcus

#40

20130004535

2013-01-03

Multiple vaccination including serogroup C meningococcus

#41

20130004532

2013-01-03

Process for manufacturing vaccines

#42

20120207780

2012-08-16

Vaccine composition

#43

20120195937

2012-08-02

POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES

#44

20110311575

2011-12-22

Mixing lyophilised meningococcal vaccines with D-T-Pa vaccines

#45

20110311574

2011-12-22

Multiple vaccination including serogroup C Meningococcus

#46

20110212124

2011-09-01

Vaccine Composition

#47

20110206726

2011-08-25

Combination vaccine with acellular pertussis

#48

20110195087

2011-08-11

COMBINATION VACCINE WITH WHOLE CELL PERTUSSIS

#49

20110189226

2011-08-04

Immunization compositions and methods

#50

20100233201

2010-09-16

Polyanionic polymer adjuvants for B saccharide vaccines

#51

20100226937

2010-09-09

COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE

#52

20100215686

2010-08-26

Process for manufacturing vaccines

#53

20100158940

2010-06-24

MANUFACTURE OF BOOSTER VACCINES HAVING REDUCED ANTIGEN DOSES

#54

20100074918

2010-03-25

VACCINE

#55

20100040647

2010-02-18

Inactivated polio vaccines

#56

20100034850

2010-02-11

Vaccine

#57

20100034847

2010-02-11

Multiple vaccination including serogroup C meningococcus

#58

20100021497

2010-01-28

IPV-DPT vaccine

#59

20090252759

2009-10-08

Immunogenic composition

#60

20090181050

2009-07-16

Manufacturing Method of Combined Vaccine

#61

20090136541

2009-05-28

Immunogenic composition

#62

20090123496

2009-05-14

Purification of HBV antigens for use in vaccines

#63

20090041802

2009-02-12

Immunogenic composition

#64

20080305127

2008-12-11

Conjugate Vaccines

#65

20080199490

2008-08-21

Immunogenic composition

#66

20080193476

2008-08-14

Immunogenic composition

#67

20080069835

2008-03-20

VACCINE COMPOSITION

#68

20070082014

2007-04-12

Injectable vaccines against multiple meningococcal serogroups

#69

20060159705

2006-07-20

Purification of HBV antigens for use in vaccines

#70

20060121059

2006-06-08

Polyanionic polymer adjuvants for haemophilus influenzae B saccharide vaccines